Work

Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trial – Authors' reply

Year: 2024

Type: letter

Source: The Lancet

DOI: 10.1016/s0140-6736(24)01049-3

Authors: Hope S Rugo, Aditya Bardia, Sara Tolaney

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4401022540

Cites: 3

Cited by:

Related to: 10